Quest Diagnostics Incorporated (0KSX.L)
USD 152.97
(-2.05%)
USD 152.97
(-2.05%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 14.02 Billion USD | 9.23% |
| 2022 | 12.83 Billion USD | -5.69% |
| 2021 | 13.61 Billion USD | -2.96% |
| 2020 | 14.02 Billion USD | 9.21% |
| 2019 | 12.84 Billion USD | 16.72% |
| 2018 | 11 Billion USD | 4.76% |
| 2017 | 10.5 Billion USD | 3.99% |
| 2016 | 10.1 Billion USD | 1.39% |
| 2015 | 9.96 Billion USD | 0.86% |
| 2014 | 9.87 Billion USD | 10.38% |
| 2013 | 8.94 Billion USD | -3.62% |
| 2012 | 9.28 Billion USD | -0.32% |
| 2011 | 9.31 Billion USD | 9.21% |
| 2010 | 8.52 Billion USD | -0.42% |
| 2009 | 8.56 Billion USD | 1.9% |
| 2008 | 8.4 Billion USD | -1.89% |
| 2007 | 8.56 Billion USD | 51.3% |
| 2006 | 5.66 Billion USD | 6.7% |
| 2005 | 5.3 Billion USD | 26.22% |
| 2004 | 4.2 Billion USD | -2.27% |
| 2003 | 4.3 Billion USD | 29.4% |
| 2002 | 3.32 Billion USD | 13.43% |
| 2001 | 2.93 Billion USD | 2.3% |
| 2000 | 2.86 Billion USD | -0.49% |
| 1999 | 2.87 Billion USD | 111.62% |
| 1998 | 1.36 Billion USD | -2.91% |
| 1997 | 1.4 Billion USD | 0.42% |
| 1996 | 1.39 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 13.88 Billion USD | -0.52% |
| 2024 Q1 | 13.95 Billion USD | -0.48% |
| 2024 Q3 | 16.09 Billion USD | 15.95% |
| 2023 Q3 | 13.48 Billion USD | 0.42% |
| 2023 Q2 | 13.42 Billion USD | 4.93% |
| 2023 FY | 14.02 Billion USD | 9.23% |
| 2023 Q4 | 14.02 Billion USD | 4.01% |
| 2023 Q1 | 12.79 Billion USD | -0.33% |
| 2022 FY | 12.83 Billion USD | -5.69% |
| 2022 Q3 | 13.22 Billion USD | -0.67% |
| 2022 Q4 | 12.83 Billion USD | -2.92% |
| 2022 Q1 | 13.44 Billion USD | -1.24% |
| 2022 Q2 | 13.31 Billion USD | -0.97% |
| 2021 Q4 | 13.61 Billion USD | 0.29% |
| 2021 Q3 | 13.57 Billion USD | 5.53% |
| 2021 FY | 13.61 Billion USD | -2.96% |
| 2021 Q1 | 13.93 Billion USD | -0.68% |
| 2021 Q2 | 12.86 Billion USD | -7.68% |
| 2020 Q2 | 12.99 Billion USD | 7.81% |
| 2020 Q3 | 14.14 Billion USD | 8.88% |
| 2020 FY | 14.02 Billion USD | 9.21% |
| 2020 Q1 | 12.04 Billion USD | -6.18% |
| 2020 Q4 | 14.02 Billion USD | -0.83% |
| 2019 Q4 | 12.84 Billion USD | 6.86% |
| 2019 FY | 12.84 Billion USD | 16.72% |
| 2019 Q1 | 11.93 Billion USD | 8.49% |
| 2019 Q2 | 11.76 Billion USD | -1.48% |
| 2019 Q3 | 12.01 Billion USD | 2.2% |
| 2018 Q3 | 10.98 Billion USD | 2.22% |
| 2018 FY | 11 Billion USD | 4.76% |
| 2018 Q4 | 11 Billion USD | 0.15% |
| 2018 Q2 | 10.74 Billion USD | 0.49% |
| 2018 Q1 | 10.69 Billion USD | 1.83% |
| 2017 FY | 10.5 Billion USD | 3.99% |
| 2017 Q2 | 10.17 Billion USD | 0.61% |
| 2017 Q1 | 10.1 Billion USD | 0.09% |
| 2017 Q4 | 10.5 Billion USD | 0.61% |
| 2017 Q3 | 10.43 Billion USD | 2.63% |
| 2016 FY | 10.1 Billion USD | 1.39% |
| 2016 Q1 | 10.09 Billion USD | 1.36% |
| 2016 Q2 | 10.1 Billion USD | 0.12% |
| 2016 Q3 | 10.17 Billion USD | 0.63% |
| 2016 Q4 | 10.1 Billion USD | -0.72% |
| 2015 Q1 | 10.61 Billion USD | 7.45% |
| 2015 Q3 | 10.07 Billion USD | 3.64% |
| 2015 Q4 | 9.96 Billion USD | -1.11% |
| 2015 FY | 9.96 Billion USD | 0.86% |
| 2015 Q2 | 9.72 Billion USD | -8.41% |
| 2014 Q3 | 9.8 Billion USD | 0.45% |
| 2014 FY | 9.87 Billion USD | 10.38% |
| 2014 Q1 | 9.55 Billion USD | 6.73% |
| 2014 Q2 | 9.75 Billion USD | 2.17% |
| 2014 Q4 | 9.87 Billion USD | 0.78% |
| 2013 Q2 | 9.03 Billion USD | -2.9% |
| 2013 Q4 | 8.94 Billion USD | 0.23% |
| 2013 Q3 | 8.92 Billion USD | -1.2% |
| 2013 Q1 | 9.3 Billion USD | 0.24% |
| 2013 FY | 8.94 Billion USD | -3.62% |
| 2012 FY | 9.28 Billion USD | -0.32% |
| 2012 Q1 | 9.45 Billion USD | 1.48% |
| 2012 Q2 | 9.39 Billion USD | -0.62% |
| 2012 Q3 | 9.31 Billion USD | -0.79% |
| 2012 Q4 | 9.28 Billion USD | -0.37% |
| 2011 Q3 | 9.32 Billion USD | -1.11% |
| 2011 Q1 | 9.18 Billion USD | 7.69% |
| 2011 FY | 9.31 Billion USD | 9.21% |
| 2011 Q4 | 9.31 Billion USD | -0.14% |
| 2011 Q2 | 9.43 Billion USD | 2.7% |
| 2010 Q1 | 8.51 Billion USD | -0.55% |
| 2010 FY | 8.52 Billion USD | -0.42% |
| 2010 Q3 | 8.45 Billion USD | -0.27% |
| 2010 Q4 | 8.52 Billion USD | 0.81% |
| 2010 Q2 | 8.48 Billion USD | -0.4% |
| 2009 FY | 8.56 Billion USD | 1.9% |
| 2009 Q1 | 8.34 Billion USD | -0.68% |
| 2009 Q2 | 8.21 Billion USD | -1.62% |
| 2009 Q3 | 8.36 Billion USD | 1.88% |
| 2009 Q4 | 8.56 Billion USD | 2.37% |
| 2008 Q1 | 8.64 Billion USD | 0.94% |
| 2008 FY | 8.4 Billion USD | -1.89% |
| 2008 Q4 | 8.4 Billion USD | -1.92% |
| 2008 Q2 | 8.56 Billion USD | -0.92% |
| 2008 Q3 | 8.56 Billion USD | 0.02% |
| 2007 FY | 8.56 Billion USD | 51.3% |
| 2007 Q1 | 6.18 Billion USD | 9.27% |
| 2007 Q3 | 8.58 Billion USD | 1.04% |
| 2007 Q4 | 8.56 Billion USD | -0.2% |
| 2007 Q2 | 8.49 Billion USD | 37.3% |
| 2006 Q2 | 5.44 Billion USD | 0.24% |
| 2006 Q3 | 5.7 Billion USD | 4.72% |
| 2006 Q4 | 5.66 Billion USD | -0.76% |
| 2006 Q1 | 5.43 Billion USD | 2.42% |
| 2006 FY | 5.66 Billion USD | 6.7% |
| 2005 Q3 | 4.53 Billion USD | 0.6% |
| 2005 Q4 | 5.3 Billion USD | 17.01% |
| 2005 Q2 | 4.5 Billion USD | 3.81% |
| 2005 Q1 | 4.34 Billion USD | 3.29% |
| 2005 FY | 5.3 Billion USD | 26.22% |
| 2004 FY | 4.2 Billion USD | -2.27% |
| 2004 Q4 | 4.2 Billion USD | -4.35% |
| 2004 Q3 | 4.39 Billion USD | 1.11% |
| 2004 Q2 | 4.34 Billion USD | -0.76% |
| 2004 Q1 | 4.38 Billion USD | 1.83% |
| 2003 FY | 4.3 Billion USD | 29.4% |
| 2003 Q4 | 4.3 Billion USD | 0.95% |
| 2003 Q3 | 4.26 Billion USD | 0.39% |
| 2003 Q2 | 4.24 Billion USD | 1.38% |
| 2003 Q1 | 4.18 Billion USD | 25.93% |
| 2002 Q4 | 3.32 Billion USD | -4.08% |
| 2002 FY | 3.32 Billion USD | 13.43% |
| 2002 Q3 | 3.46 Billion USD | 0.41% |
| 2002 Q2 | 3.45 Billion USD | 14.83% |
| 2002 Q1 | 3 Billion USD | 2.56% |
| 2001 Q3 | 2.93 Billion USD | 1.21% |
| 2001 FY | 2.93 Billion USD | 2.3% |
| 2001 Q4 | 2.93 Billion USD | -0.1% |
| 2001 Q1 | 2.9 Billion USD | 1.35% |
| 2001 Q2 | 2.89 Billion USD | -0.17% |
| 2000 Q1 | 2.83 Billion USD | -1.38% |
| 2000 Q2 | 2.93 Billion USD | 3.46% |
| 2000 Q4 | 2.86 Billion USD | -4.71% |
| 2000 FY | 2.86 Billion USD | -0.49% |
| 2000 Q3 | 3 Billion USD | 2.36% |
| 1999 Q4 | 2.87 Billion USD | 1.84% |
| 1999 FY | 2.87 Billion USD | 111.62% |
| 1999 Q1 | 1.31 Billion USD | -3.09% |
| 1999 Q2 | 1.31 Billion USD | -0.41% |
| 1999 Q3 | 2.82 Billion USD | 115.31% |
| 1998 FY | 1.36 Billion USD | -2.91% |
| 1998 Q4 | 1.36 Billion USD | -0.44% |
| 1998 Q1 | 1.4 Billion USD | 0.19% |
| 1998 Q3 | 1.36 Billion USD | 0.15% |
| 1998 Q2 | 1.36 Billion USD | -2.81% |
| 1997 Q4 | 1.4 Billion USD | -1.46% |
| 1997 Q2 | 1.39 Billion USD | 0.84% |
| 1997 Q1 | 1.38 Billion USD | -0.67% |
| 1997 FY | 1.4 Billion USD | 0.42% |
| 1997 Q3 | 1.42 Billion USD | 1.75% |
| 1996 Q4 | 1.39 Billion USD | -26.03% |
| 1996 Q3 | 1.88 Billion USD | 0.0% |
| 1996 FY | 1.39 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -3678.649% |
| Accuray Incorporated | 468.62 Million USD | -2892.145% |
| Align Technology, Inc. | 6.08 Billion USD | -130.478% |
| Elevance Health Inc. | 108.92 Billion USD | 87.127% |
| AxoGen, Inc. | 196.82 Million USD | -7024.023% |
| Boston Scientific Corporation | 35.13 Billion USD | 60.092% |
| CVS Health Corporation | 249.72 Billion USD | 94.385% |
| Cardinal Health, Inc. | 45.12 Billion USD | 68.924% |
| Centene Corporation | 84.64 Billion USD | 83.434% |
| DaVita Inc. | 17.61 Billion USD | 20.418% |
| HCA Healthcare, Inc. | 56.21 Billion USD | 75.055% |
| Hologic, Inc. | 9.15 Billion USD | -53.145% |
| Humana Inc. | 47.06 Billion USD | 70.207% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -330.133% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | 16.162% |
| Masimo Corporation | 3.04 Billion USD | -361.023% |
| McKesson Corporation | 67.44 Billion USD | 79.209% |
| Patterson Companies, Inc. | 2.96 Billion USD | -372.27% |
| ResMed Inc. | 6.87 Billion USD | -104.034% |
| Henry Schein, Inc. | 10.57 Billion USD | -32.621% |
| Teladoc Health, Inc. | 4.39 Billion USD | -219.235% |
| Universal Health Services, Inc. | 14.35 Billion USD | 2.332% |
| Veeva Systems Inc. | 5.91 Billion USD | -137.222% |
| Baxter International Inc. | 28.27 Billion USD | 50.41% |
| Becton, Dickinson and Company | 52.78 Billion USD | 73.433% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 9.193% |
| Danaher Corporation | 84.48 Billion USD | 83.404% |
| Stryker Corporation | 39.91 Billion USD | 64.868% |
| Medtronic plc | 89.98 Billion USD | 84.417% |